{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320679532928.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0140-6736(98)07236-5"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0140673698072365?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0140673698072365?httpAccept=text/plain"}},{"identifier":{"@type":"NAID","@value":"30005703351"}}],"dc:title":[{"@value":"Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1581135651166651264","@type":"Researcher","foaf:name":[{"@language":"en","@value":"International Interferon alpha Hepatocellular carcinoma Study Group."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01406736"}],"prism:publicationName":[{"@value":"The Lancet"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1998-05","prism:volume":"351","prism:number":"9115","prism:startingPage":"1535","prism:endingPage":"1539"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0140673698072365?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0140673698072365?httpAccept=text/plain"}],"createdAt":"2002-07-25","modifiedAt":"2024-12-04","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285706236845440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320598109056","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of Previous Interferon Therapy on Recurrence after Resection of Hepatitis C Virus‐related Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204790046976","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"インターフェロンα‐２ｂ投与中にＳｔｅｖｅｎｓ‐Ｊｏｈｎｓｏｎ症候群を発症し，１０週間投与にて著効が得られた常習飲酒家Ｃ型肝硬変の１例"},{"@language":"en","@value":"A Case of Liver Cirrhosis with Stevens-Johnson Syndrome Who Showed Complete Response After Short Term Interferon Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204870037376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206397014400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"肝線維化研究と治療の最前線　　肝線維化治療の最前線"},{"@language":"en","@value":"Forefront of therapy for hepatic fibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447135488","@type":"Article","resourceType":"other","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"7. Cutting Edge of the Treatment for Viral Hepatitis"},{"@language":"ja","@value":"7．ウイルス性肝炎の治療の進歩"},{"@value":"教育講演 ウイルス性肝炎の治療の進歩"},{"@language":"ja-Kana","@value":"キョウイク コウエン ウイルスセイ カンエン ノ チリョウ ノ シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679843843456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regression of Liver Fibrosis in Cases of Chronic Liver Disease Type C: Quantitative Evaluation by Using Computed Image Analysis"},{"@value":"Regression of Liver Fibrosis in Patients Treated By Interferon"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681373082368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Ｂ型肝炎治療の新しい展開　　肝硬変に対する抗ウイルス療法"},{"@language":"en","@value":"Antiviral therapy for liver cirrhosis type B"}]},{"@id":"https://cir.nii.ac.jp/crid/1520009408607953920","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"インターフェロン著効C型肝炎例における肝発癌危険因子としての血清鉄値の有用性"},{"@language":"ja-Kana","@value":"インターフェロン チョコウ Cガタ カンエンレイ ニ オケル カンハツガン キケン インシ ト シテ ノ ケッセイテツチ ノ ユウヨウセイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750933595520","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291225117027456","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"C型慢性肝炎の診断と治療"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291225164432896","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854175117794432","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C : a pilot study"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417124438114816","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pretreatment viral load and response to interferon therapy for liver cirrhosis caused by hepatitis C virus: a multicenter controlled study"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550373244160","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antiviral therapy and primary and secondary prevention of hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1572543025071455360","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Early liver cancer : concepts, diagnosis, and management"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824500331406464","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449269477888","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Different clinicopathological features of hepatocellular carcinoma in relation to causative agents"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924700246656","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment strategies for chronic hepatitis C virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668925136359424","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0140-6736(98)07236-5"},{"@type":"CIA","@value":"30005703351"},{"@type":"CROSSREF","@value":"10.1007/s00535-012-0679-8_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.43.902_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.47.1087_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"},{"@type":"CROSSREF","@value":"10.2169/naika.101.2681_references_DOI_Qu1fnOTPgbHD85BrEsfLZ08g4Vo"}]}